Literature DB >> 29688554

Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana.

Rebecca Zash1,2,3, Kathryn Rough4,5, Denise L Jacobson6, Modiegi Diseko3, Gloria Mayondi3, Mompati Mmalane3, Max Essex2,3, Chipo Petlo7, Shahin Lockman2,3,8, Joseph Makhema3, Roger L Shapiro2,3.   

Abstract

Among human immunodeficiency virus-positive women in Botswana on the recommended first-line antiretroviral therapy regimen, tenofovir-emtricitabine-efavirenz, initiated within the first or early second trimester, we found no increased risk of stillbirth, neonatal death, preterm/very preterm delivery, or the infant being born small or very small for gestational age. Treatment with tenofovir-emtricitabine-efavirenz <1 year before conception increased the risk of preterm delivery slightly over late-second-trimester treatment initiation (adjusted risk ratio, 1.33 [95% confidence interval, 1.04-1.70]).

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29688554      PMCID： PMC6097579          DOI： 10.1093/jpids/piy006

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  7 in total

1.  INTERGROWTH-21st very preterm size at birth reference charts.

Authors:  José Villar; Francesca Giuliani; Tanis R Fenton; Eric O Ohuma; Leila Cheikh Ismail; Stephen H Kennedy
Journal:  Lancet       Date:  2016-02-18       Impact factor: 79.321

2.  Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

Authors:  Rebecca Zash; Denise L Jacobson; Modiegi Diseko; Gloria Mayondi; Mompati Mmalane; Max Essex; Chipo Petlo; Shahin Lockman; Joseph Makhema; Roger L Shapiro
Journal:  JAMA Pediatr       Date:  2017-10-02       Impact factor: 16.193

3.  Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana.

Authors:  Rebecca Zash; Sajini Souda; Jennifer Y Chen; Kelebogile Binda; Scott Dryden-Peterson; Shahin Lockman; Mompati Mmalane; Joseph Makhema; Max Essex; Roger Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

4.  Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?

Authors:  Jeanne Sibiude; Josiane Warszawski; Roland Tubiana; Catherine Dollfus; Albert Faye; Christine Rouzioux; Jean-Paul Teglas; Dieudonné Ekoukou; Stéphane Blanche; Laurent Mandelbrot
Journal:  Clin Infect Dis       Date:  2012-03-28       Impact factor: 9.079

5.  Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Authors:  Jennifer Y Chen; Heather J Ribaudo; Sajini Souda; Natasha Parekh; Anthony Ogwu; Shahin Lockman; Kathleen Powis; Scott Dryden-Peterson; Tracy Creek; William Jimbo; Tebogo Madidimalo; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

6.  International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project.

Authors:  José Villar; Leila Cheikh Ismail; Cesar G Victora; Eric O Ohuma; Enrico Bertino; Doug G Altman; Ann Lambert; Aris T Papageorghiou; Maria Carvalho; Yasmin A Jaffer; Michael G Gravett; Manorama Purwar; Ihunnaya O Frederick; Alison J Noble; Ruyan Pang; Fernando C Barros; Cameron Chumlea; Zulfiqar A Bhutta; Stephen H Kennedy
Journal:  Lancet       Date:  2014-09-06       Impact factor: 79.321

Review 7.  Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis.

Authors:  Olalekan A Uthman; Jean B Nachega; Jean Anderson; Steve Kanters; Edward J Mills; Françoise Renaud; Shaffiq Essajee; Meg C Doherty; Lynne M Mofenson
Journal:  Lancet HIV       Date:  2016-11-16       Impact factor: 12.767
  7 in total
  4 in total

1.  Outcomes Following Pregnancy Conception on Antiretroviral Therapy: A Call for More Data.

Authors:  Shahin Lockman; Victor De Gruttola
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079

2.  No Difference in Growth Outcomes up to 24 Months of Age by Duration of Exposure to Maternal Antiretroviral Therapy Among Children Who Are HIV-Exposed and Uninfected in Malawi.

Authors:  Gabriela Toledo; Megan Landes; Monique van Lettow; Beth A Tippett Barr; Heather Bailey; Claire Thorne; Siobhan Crichton
Journal:  Front Pediatr       Date:  2022-06-20       Impact factor: 3.569

3.  Adverse Pregnancy Outcomes Among HIV-positive Women in the Era of Universal Antiretroviral Therapy Remain Elevated Compared With HIV-negative Women.

Authors:  Vincent J Tukei; Heather J Hoffman; Lauren Greenberg; Ramatlapeng Thabelo; Masepeli Nchephe; Tsietso Mots'oane; Matseliso Masitha; Mammatli Chabela; Majoalane Mokone; Lynne Mofenson; Laura Guay; Appolinaire Tiam
Journal:  Pediatr Infect Dis J       Date:  2021-09-01       Impact factor: 3.806

Review 4.  A Scoping Review of Preterm Births in Sub-Saharan Africa: Burden, Risk Factors and Outcomes.

Authors:  Adam Mabrouk; Amina Abubakar; Ezra Kipngetich Too; Esther Chongwo; Ifedayo M Adetifa
Journal:  Int J Environ Res Public Health       Date:  2022-08-24       Impact factor: 4.614
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.